Cellebrite DI (CLBT) Equity Average (2021 - 2025)

Cellebrite DI (CLBT) has reported Equity Average for 5 consecutive years, with $466.0 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Equity Average rose 46.93% year-over-year to $466.0 million; the TTM figure through Dec 2025 stood at $466.0 million (up 46.93% YoY), while the FY2025 annual figure was $410.2 million, up 121.57% from the prior year.
• Equity Average came in at $466.0 million for Q4 2025 at Cellebrite DI, up from $428.0 million in the prior quarter.
• The five-year high for Equity Average was $466.0 million in Q4 2025, with the low at -$101.7 million in Q4 2021.
• Average Equity Average over 5 years is $127.4 million, with a median of $41.8 million recorded in 2022.
• Across the five-year window, Equity Average slumped 217.49% in 2024 and jumped 9219.4% in 2025, its largest moves.
• Year by year, Equity Average stood at -$101.7 million in 2021, then soared by 165.57% to $66.7 million in 2022, then sank by 45.88% to $36.1 million in 2023, then soared by 779.14% to $317.2 million in 2024, then surged by 46.93% to $466.0 million in 2025.
• According to Business Quant data, Equity Average over the past three periods registered $466.0 million, $428.0 million, and $386.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.